NASDAQ:XWEL XWELL (XWEL) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free XWEL Stock Alerts $1.79 +0.02 (+1.13%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$1.73▼$1.9050-Day Range$1.34▼$2.0752-Week Range$1.26▼$6.40Volume8,740 shsAverage Volume9,093 shsMarket Capitalization$7.48 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get XWELL alerts: Email Address XWELL MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside291.1% Upside$7.00 Price TargetShort InterestHealthy1.62% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.02 out of 5 stars 3.5 Analyst's Opinion Consensus RatingXWELL has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageXWELL has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.62% of the float of XWELL has been sold short.Short Interest Ratio / Days to CoverXWELL has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in XWELL has recently decreased by 3.81%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldXWELL does not currently pay a dividend.Dividend GrowthXWELL does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for XWEL. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for XWELL this week, compared to 1 article on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, XWELL insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.90% of the stock of XWELL is held by insiders.Percentage Held by InstitutionsOnly 8.67% of the stock of XWELL is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of XWELL is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of XWELL is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXWELL has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About XWELL Stock (NASDAQ:XWEL)XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.Read More XWEL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XWEL Stock News HeadlinesMay 2, 2024 | globenewswire.comXpresSpa Introduces IV Hydration Drip Therapy at Miami International AirportApril 19, 2024 | finance.yahoo.comXWELL Inc (XWEL) Q4 2023 Earnings Call Transcript Highlights: Strategic Expansions and Cost ...May 4, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...April 18, 2024 | investing.comEarnings call: XWELL reports growth and expansion amid financial restatementApril 18, 2024 | seekingalpha.comXWELL, Inc. (XWEL) Q4 2023 Earnings Call TranscriptApril 17, 2024 | finance.yahoo.comXWELL, Inc. (NASDAQ:XWEL) Q4 2023 Earnings Call TranscriptApril 17, 2024 | investorplace.comXWEL Stock Earnings: XWELL Misses EPS, Misses Revenue for Q4 2023April 16, 2024 | finance.yahoo.comXWELL, Inc. Reports Fiscal Year 2023 ResultsMay 4, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...April 16, 2024 | globenewswire.comXWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024April 1, 2024 | finance.yahoo.comXWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-KApril 1, 2024 | globenewswire.comXWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-KMarch 16, 2024 | finance.yahoo.comDNA Apr 2024 0.500 putMarch 15, 2024 | finance.yahoo.comDNA May 2024 1.500 putMarch 12, 2024 | msn.comUS airport nasal swabbing expanding to Chicago and MiamiMarch 12, 2024 | msn.comU.S. airport nasal swabbing expanding to Chicago and MiamiMarch 12, 2024 | prnewswire.comCDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and ChicagoFebruary 22, 2024 | benzinga.comXWELL Stock (NASDAQ:XWEL) Dividends: History, Yield and DatesFebruary 14, 2024 | finance.yahoo.comXWELL Advances Expansion Plan Outside the Airport with Three New Naples Wax and Skin Care LocationsJanuary 5, 2024 | bizjournals.comXpresSpa targets New York City's Penn Station for expansion beyond airportsJanuary 4, 2024 | finance.yahoo.comXWELL Announces Plans to Open an XpresSpa in THE PENN DISTRICTDecember 15, 2023 | finance.yahoo.comXWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of DirectorsDecember 11, 2023 | finance.yahoo.comXpresSpa Introduces Clockwork Robotic Manicures at Harry Reid International Airport in Las VegasNovember 16, 2023 | marketwatch.comXWELL Inc.November 16, 2023 | uk.finance.yahoo.comXWELL, Inc. (XWEL) stock price, news, quote & history – Yahoo FinanceNovember 16, 2023 | msn.comXWELL, Xeris Biopharma among healthcare moversNovember 15, 2023 | finance.yahoo.comXWELL Opens New XpresSpa Location in Abu Dhabi International AirportSee More Headlines Receive XWEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for XWELL and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/16/2024Today5/04/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Personal services Sub-IndustryN/A Current SymbolNASDAQ:XWEL CUSIPN/A CIK1410428 Webwww.xwell.com Phone(212) 750-9595Fax309-410-3967Employees266Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+291.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($6.75) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-27,740,000.00 Net Margins-92.14% Pretax Margin-92.98% Return on Equity-65.58% Return on Assets-41.35% Debt Debt-to-Equity RatioN/A Current Ratio2.85 Quick Ratio2.75 Sales & Book Value Annual Sales$30.11 million Price / Sales0.25 Cash FlowN/A Price / Cash FlowN/A Book Value$5.02 per share Price / Book0.36Miscellaneous Outstanding Shares4,180,000Free Float3,978,000Market Cap$7.48 million OptionableOptionable Beta2.39 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Scott R. Milford (Age 60)President, CEO & Director Comp: $595.17kMr. Ezra T. Ernst (Age 55)Executive Vice President Comp: $325.43kMr. Omar A. Haynes (Age 41)VP of Treasury & Finance Comp: $353.11kMs. Suzanne Scrabis (Age 54)Chief Financial Officer Mr. David KohelChief Technology OfficerMs. Cara SofferSenior VP & General CounselPablo HendersonChief Marketing OfficerMore ExecutivesKey CompetitorsMEDIROM Healthcare TechnologiesNYSE:MRMPlus TherapeuticsNASDAQ:PSTVHepion PharmaceuticalsNASDAQ:HEPAAquaBounty TechnologiesNASDAQ:AQBASLAN PharmaceuticalsNASDAQ:ASLNView All CompetitorsInsidersRobert WeinsteinBought 1,250 shares on 5/30/2023Total: $6,250.00 ($5.00/share)Robert WeinsteinBought 1,250 shares on 5/26/2023Total: $6,250.00 ($5.00/share)View All Insider Transactions XWEL Stock Analysis - Frequently Asked Questions Should I buy or sell XWELL stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for XWELL in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" XWEL shares. View XWEL analyst ratings or view top-rated stocks. What is XWELL's stock price target for 2024? 1 Wall Street research analysts have issued 1-year price targets for XWELL's shares. Their XWEL share price targets range from $7.00 to $7.00. On average, they anticipate the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 291.1% from the stock's current price. View analysts price targets for XWEL or view top-rated stocks among Wall Street analysts. How have XWEL shares performed in 2024? XWELL's stock was trading at $1.74 on January 1st, 2024. Since then, XWEL shares have increased by 2.9% and is now trading at $1.79. View the best growth stocks for 2024 here. Are investors shorting XWELL? XWELL saw a increase in short interest in March. As of March 31st, there was short interest totaling 68,300 shares, an increase of 23.3% from the March 15th total of 55,400 shares. Based on an average trading volume of 12,500 shares, the short-interest ratio is currently 5.5 days. Currently, 1.7% of the shares of the stock are short sold. View XWELL's Short Interest. When is XWELL's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our XWEL earnings forecast. How were XWELL's earnings last quarter? XWELL, Inc. (NASDAQ:XWEL) announced its quarterly earnings results on Tuesday, April, 16th. The company reported ($1.57) EPS for the quarter. The firm earned $7.40 million during the quarter. XWELL had a negative trailing twelve-month return on equity of 65.58% and a negative net margin of 92.14%. When did XWELL's stock split? Shares of XWELL reverse split on Thursday, September 28th 2023. The 1-20 reverse split was announced on Thursday, September 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of XWELL? Shares of XWEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:XWEL) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XWELL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
